According to GuruFocus Insider Data, these are the largest CEO buys during the past week. The overall trend of CEOs is illustrated in the chart below:
Air Products & Chemicals Inc (APD, Financial): Chairman, Pres. and CEO Seifi Ghasemi Bought 25,000 Shares
Chairman, Pres. and CEO of Air Products & Chemicals Inc (APD, Financial) Seifi Ghasemi bought 25,000 shares on 08/01/2014 at an average price of $133.12. Air Products and Chemicals, Inc. is a Delaware corporation originally founded in 1940.
Air Products & Chemicals Inc has a market cap of $28.36 billion; its shares were traded at around $133.12 with a P/E ratio of 27.90 and P/S ratio of 2.76. The dividend yield of Air Products & Chemicals Inc stocks is 2.22%. Air Products & Chemicals Inc had an annual average earnings growth of 4.60% over the past 10 years. GuruFocus rated Air Products & Chemicals Inc the business predictability rank of 2-star.
APD recently reported third quarter results led by strong performance in Merchant Gases, and Electronics and Performance Materials. For the quarter ended June 30, 2014, net income was $314 million, up nine percent, and diluted earnings per share (EPS) was $1.46, an increase of seven percent, compared with results for the third quarter of 2013.
Chris Shumway (Trades, Portfolio) owns 2,096,581 shares as of 12/31/2010, an increase of 50.47% from the previous quarter. This position accounts for 2.56% of the $7.45 billion portfolio of Shumway Capital Partners LLC. Mario Gabelli (Trades, Portfolio) owns 16,050 shares as of 03/31/2014, a decrease of 52.16% of from the previous quarter. This position accounts for 0.01% of the $18.53 billion portfolio of GAMCO Investors.
SR VP and General Counsel John D. Stanley sold 11,721 shares of APD stock on 07/25/2014 at the average price of 135.53. John D. Stanley owns at least 29,864 shares after this. The price of the stock has decreased by 1.78% since.
Ocular Therapeutix Inc (OCUL, Financial): President and CEO, 10% Owner Amarpreet Sawhney Bought 76,922 Shares
President and CEO, 10% Owner of Ocular Therapeutix Inc (OCUL, Financial) Amarpreet Sawhney bought 76,922 shares on 07/30/2014 at an average price of $13.04. Ocular Therapeutix Inc has a market cap of $268.226 million; its shares were traded at around $13.04 with and P/S ratio of 10000.00.
10% Owner Iv, Llc Svlsf bought 715,380 shares of OCUL stock on 07/30/2014 at the average price of 13. Iv, Llc Svlsf owns at least 2,585,607 shares after this. The price of the stock has increased by 0.31% since.
Conmed Corp (CNMD, Financial): Interim CEO Curt R Hartman Bought 10,000 Shares
Interim CEO of Conmed Corp (CNMD, Financial) Curt R Hartman bought 10,000 shares on 07/31/2014 at an average price of $38.45. Conmed Corporation was incorporated under the laws of the State of New York in 1970. Conmed Corp has a market cap of $1.05 billion; its shares were traded at around $38.45 with a P/E ratio of 30.90 and P/S ratio of 1.43. The dividend yield of Conmed Corp stocks is 1.95%. Conmed Corp had an annual average earnings growth of 3.00% over the past 10 years.
Conmed recently reported its second quarter 2014 financial results. Diluted earnings per share (GAAP) grew to $0.37, an increase of 8.8% compared to $0.34 in the second quarter of 2013. Adjusted diluted earnings per share increased 9.3% to $0.47 compared to $0.43 in the prior year period.
Joel Greenblatt (Trades, Portfolio) bought 13,467 shares in the quarter that ended on 03/31/2014, which is 0.0088% of the $6.64 billion portfolio of Gotham Asset Management, LLC. John Keeley (Trades, Portfolio) owns 54,620 shares as of 03/31/2014, which accounts for 0.041% of the $5.81 billion portfolio of Keeley Asset Management Corp. Mario Gabelli (Trades, Portfolio) owns 93,000 shares as of 03/31/2014, which accounts for 0.022% of the $18.53 billion portfolio of GAMCO Investors.
Director Bruce Daniels sold 1,600 shares of CNMD stock on 07/30/2014 at the average price of 39.31. Bruce Daniels owns at least 5,000 shares after this. The price of the stock has decreased by 2.19% since.
Opko Health Inc (OPK, Financial): CEO & Chairman, 10% Owner Phillip Md Et Al Frost Bought 43,500 Shares
CEO & Chairman, 10% Owner of Opko Health Inc (OPK, Financial) Phillip Md Et Al Frost bought 43,500 shares on 07/30/2014 at an average price of $8.74. Opko Health, Inc. was originally incorporated in Delaware in October 1991 under the name Cytoclonal Pharmaceutics, Inc. Opko Health Inc has a market cap of $3.62 billion; its shares were traded at around $8.74 with and P/S ratio of 38.00. Opko Health Inc had an annual average earnings growth of 5.40% over the past 10 years.
George Soros (Trades, Portfolio) owns 1,494,800 shares as of 03/31/2014, an increase of 76.98% from the previous quarter. This position accounts for 0.14% of the $10.12 billion portfolio of Soros Fund Management LLC.
Vice Chairman & CTO Jane Ph D Hsiao bought 10,000 shares of OPK stock on 04/15/2014 at the average price of 8.03. Jane Ph D Hsiao owns at least 21,338,212 shares after this. The price of the stock has increased by 8.84% since.
Aegerion Pharmaceuticals Inc (AEGR, Financial): CEO Marc D Beer Bought 10,000 Shares
CEO of Aegerion Pharmaceuticals Inc (AEGR, Financial) Marc D Beer bought 10,000 shares on 07/31/2014 at an average price of $33.22. Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company. Aegerion Pharmaceuticals Inc has a market cap of $979.424 million; its shares were traded at around $33.22 with and P/S ratio of 13.03.
Michael Price (Trades, Portfolio) bought 200,000 shares in the quarter that ended on 03/31/2014, which is 1.1% of the $821 million portfolio of MFP Investors LLC Andreas Halvorsen (Trades, Portfolio) sold out his holdings in the quarter that ended on 03/31/2014.
CFO Mark J. Fitzpatrick sold 7,500 shares of AEGR stock on 02/10/2014 at the average price of 62.61. Mark J. Fitzpatrick owns at least 5,850 shares after this. The price of the stock has decreased by 46.94% since.
